Blood Pressure-Lowering Effect of Newer Antihyperglycemic Agents (SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors) Charalampos I. LiakosDimitrios P. PapadopoulosJohn D. Barbetseas Review Article 11 August 2020 Pages: 123 - 137
The Use of Aspirin in Contemporary Primary Prevention of Atherosclerotic Cardiovascular Diseases Revisited: The Increasing Need and Call for a Personalized Therapeutic Approach Zlatko FrasAmirhossein SahebkarMaciej Banach Review Article 18 August 2020 Pages: 139 - 151
Toward Brief Dual Antiplatelet Therapy and P2Y12 Inhibitors for Monotherapy After PCI Ali AyoubKarnika AyinapudiThierry LeJemtel Review Article 11 August 2020 Pages: 153 - 163
Nebivolol for the Treatment of Essential Systemic Arterial Hypertension: A Systematic Review and Meta-Analysis VinÃcius Bocchino SelemeGustavo Lenci MarquesClaudio L. Pereira da Cunha Systematic Review 25 July 2020 Pages: 165 - 180
Efficacy and Safety of Long-Term Oral Bosentan in Different Types of Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis Hong-yu KuangQiang LiYue-hui Yin Systematic Review 12 September 2020 Pages: 181 - 191
Exploring Medication Adherence with P2Y12 Inhibitors Using Conditional and Unconditional Quantile Regression Approaches Kangho SuhAnirban BasuKelley R. Branch Original Research Article 30 March 2020 Pages: 193 - 204
Ex Ante Economic Evaluation of Arg389 Genetically Targeted Treatment with Bucindolol versus Empirical Treatment with Carvedilol in NYHA III/IV Heart Failure Nimer AlkhatibNancy K. SweitzerIvo Abraham Original Research Article 25 July 2020 Pages: 205 - 217
Optimal Medical Therapy Prescription in Patients with Acute Coronary Syndrome in the Netherlands: A Multicenter Pilot Registry Niels P. G. HoedemakerRobbert J. de WinterPeter Damman Original Research Article Open access 12 August 2020 Pages: 219 - 229
Meta-Analysis Comparing Potent Oral P2Y12 Inhibitors versus Clopidogrel in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention Matteo CasulaFederico FortuniSergio Leonardi Original Research Article Open access 08 September 2020 Pages: 231 - 240
The AWAKE-HF Study: Sacubitril/Valsartan Impact on Daily Physical Activity and Sleep in Heart Failure Raj M. KhandwallaDaniel Grantfor the AWAKE-H. F. Study Investigators Original Research Article 26 September 2020 Pages: 241 - 254